Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$20.78 - $31.77 $4.05 Million - $6.19 Million
-194,900 Reduced 92.83%
15,060 $471,000
Q3 2023

Nov 14, 2023

BUY
$20.84 - $33.47 $4.38 Million - $7.03 Million
209,960 New
209,960 $4.38 Million
Q1 2021

May 14, 2021

SELL
$25.02 - $54.99 $16.4 Million - $36 Million
-654,414 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$41.04 - $56.79 $4.02 Million - $5.56 Million
97,900 Added 17.59%
654,414 $35 Million
Q3 2020

Nov 13, 2020

BUY
$36.42 - $57.0 $7.79 Million - $12.2 Million
213,851 Added 62.41%
556,514 $23 Million
Q2 2020

Aug 13, 2020

BUY
$39.26 - $52.73 $4.13 Million - $5.55 Million
105,213 Added 44.31%
342,663 $16.6 Million
Q1 2020

May 13, 2020

BUY
$31.65 - $46.87 $2.94 Million - $4.36 Million
93,000 Added 64.38%
237,450 $10 Million
Q4 2019

Feb 12, 2020

BUY
$36.21 - $51.4 $5.23 Million - $7.42 Million
144,450 New
144,450 $6.18 Million
Q2 2018

Aug 13, 2018

SELL
$15.07 - $22.34 $11.8 Million - $17.5 Million
-783,424 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$22.47 - $32.33 $7.83 Million - $11.3 Million
-348,298 Reduced 30.78%
783,424 $17.6 Million
Q4 2017

Feb 13, 2018

BUY
$26.84 - $39.14 $8.3 Million - $12.1 Million
309,330 Added 37.61%
1,131,722 $34.1 Million
Q3 2017

Nov 14, 2017

BUY
$29.49 - $38.37 $24.3 Million - $31.6 Million
822,392
822,392 $31 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.